Definitive Contract 75N91019C00026
Award Date 9/11/19
Potential Completion Date 7/14/22
Potential Value $225K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02138, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
95
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a $1,499,973.00 Small Business Innovation Research (SBIR) Phase II contract awarded to Charles River Analytics, Inc., a small business located in Cambridge, Massachusetts. The contract was awarded by the National Cancer Institute, a civilian federal agency, to develop connected health technologies to address and improve health outcomes for long-term cancer survivors. The contract has a performance period of September 13, 2021 to September 12, 2023, with an ultimate completion date of...
- This is a $224,896 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Charles River Analytics, Inc., an employee-owned small business in Cambridge, Massachusetts. The contract is for the "TOPIC 343 - CANCER PATIENT COGNITIVE ASSESSMENT PLATFORM" and has an ultimate completion date of June 18, 2017. The contract is not designated as a set-aside. Charles River Analytics has a history of...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $224,761.00 firm fixed-price definitive contract to Charles River Analytics, Inc., a small business located in Cambridge, Massachusetts. The contract is for the development of a mobile application called "PRORAD" to support the monitoring of health-related quality of life for cancer patients undergoing radiotherapy. This contract was awarded under the NIH/Centers...
- This is a $1,499,914.00 Definitive Contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Charles River Analytics, Inc., a small business located in Cambridge, Massachusetts. The contract has a firm fixed price pricing type and a completion date of September 16, 2022. It is a total small business set-aside award. Under this contract, Charles River Analytics will provide research, development, testing, experimentation, software...
- The federal contract award is a Phase I Small Business Innovation Research contract valued at approximately $400,000 awarded by the National Institutes of Health National Cancer Institute to Charles River Analytics, Inc. of Cambridge, Massachusetts. The contract is for one year ending in June 2021 to conduct research and development in support of the agency's TOPIC 412: WEARABLE HEALTH INFORMATICS PLATFORM FOR EXTENSIBLE RESEARCH program. Specifically, the contractor will develop a wearable...
- This SBIR Phase I contract was awarded by the National Institutes of Health National Cancer Institute to Outcomes4Me Inc. for $452,514. The contract is for the period of September 16, 2020 through September 15, 2022 and involves developing mobile health technology to utilize cancer survivorship navigation for patient benefit. The solicitation sought proposals to conduct research and development in support of NIH and CDC agency missions, including topics related to cancer immunotherapy...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Cancer Institute to Carevive Systems Inc., a woman-owned small business. The contract, valued at $1,725,000.00, is for the development of "Symptom Management and Intervention Roadmaps (STAIRS) (MOONSHOT)" to contribute toward meeting the program objectives of the NIH and Centers for Disease Control and Prevention...
- This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
- This is a $399,870 firm-fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Apricity Health LLC, a small business based in Houston, Texas. The contract is for the development of "Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement" under a total small business set-aside solicitation. The original solicitation, PHS-2020-1, sought proposals from small businesses for SBIR...
- This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...